Literature DB >> 19136636

3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.

Eva Torreira1, Agustín Tortajada, Tamara Montes, Santiago Rodríguez de Córdoba, Oscar Llorca.   

Abstract

Generation of the alternative pathway C3-convertase, the central amplification enzyme of the complement cascade, initiates by the binding of factor B (fB) to C3b to form the proconvertase, C3bB. C3bB is subsequently cleaved by factor D (fD) at a single site in fB, producing Ba and Bb fragments. Ba dissociates from the complex, while Bb remains bound to C3b, forming the active alternative pathway convertase, C3bBb. Using single-particle electron microscopy we have determined the 3-dimensional structures of the C3bB and the C3bBb complexes at approximately 27A resolution. The C3bB structure shows that fB undergoes a dramatic conformational change upon binding to C3b. However, the C3b-bound fB structure was easily interpreted after independently fitting the atomic structures of the isolated Bb and Ba fragments. Interestingly, the divalent cation-binding site in the von Willebrand type A domain in Bb faces the C345C domain of C3b, whereas the serine-protease domain of Bb points outwards. The structure also shows that the Ba fragment interacts with C3b separately from Bb at the level of the alpha'NT and CUB domains. Within this conformation, the long and flexible linker between Bb and Ba is likely exposed and accessible for cleavage by fD to form the active convertase, C3bBb. The architecture of the C3bB and C3bBb complexes reveals that C3b could promote cleavage and activation of fB by actively displacing the Ba domain from the von Willebrand type A domain in free fB. These structures provide a structural basis to understand fundamental aspects of the activation and regulation of the alternative pathway C3-convertase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136636      PMCID: PMC2630071          DOI: 10.1073/pnas.0810860106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  EMAN: semiautomated software for high-resolution single-particle reconstructions.

Authors:  S J Ludtke; P R Baldwin; W Chiu
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

2.  Accurate determination of local defocus and specimen tilt in electron microscopy.

Authors:  Joseph A Mindell; Nikolaus Grigorieff
Journal:  J Struct Biol       Date:  2003-06       Impact factor: 2.867

3.  Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.

Authors:  Karthe Ponnuraj; Yuanyuan Xu; Kevin Macon; Dwight Moore; John E Volanakis; Sthanam V L Narayana
Journal:  Mol Cell       Date:  2004-04-09       Impact factor: 17.970

4.  Complement inactivation by recombinant human C3 derivatives.

Authors:  Johanna Kölln; Edzard Spillner; Jörg Andrä; Katrin Klensang; Reinhard Bredehorst
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

Review 5.  The spectrum of complement alternative pathway-mediated diseases.

Authors:  V Michael Holers
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

6.  Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb.

Authors:  Dennis E Hourcade; Lynne Mitchell; Lisa A Kuttner-Kondo; John P Atkinson; M Edward Medof
Journal:  J Biol Chem       Date:  2001-11-02       Impact factor: 5.157

7.  A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.

Authors:  Joshua M Thurman; Damian M Kraus; Guillermina Girardi; Dennis Hourcade; Hee J Kang; Pamela A Royer; Lynne M Mitchell; Patricia C Giclas; Jane Salmon; Gary Gilkeson; V Michael Holers
Journal:  Mol Immunol       Date:  2005-01       Impact factor: 4.407

8.  The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

9.  Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.

Authors:  Z Fishelson; H J Müller-Eberhard
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

10.  MHC Class III products: an electron microscopic study of the C3 convertases of human complement.

Authors:  C A Smith; C W Vogel; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

View more
  36 in total

1.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

2.  Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex.

Authors:  Nick S Laursen; Kasper R Andersen; Ingke Braren; Edzard Spillner; Lars Sottrup-Jensen; Gregers R Andersen
Journal:  EMBO J       Date:  2011-01-07       Impact factor: 11.598

Review 3.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

4.  Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.

Authors:  Martín Alcorlo; Agustín Tortajada; Santiago Rodríguez de Córdoba; Oscar Llorca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

5.  4-Hydroxy-7-oxo-5-heptenoic Acid Lactone Is a Potent Inducer of the Complement Pathway in Human Retinal Pigmented Epithelial Cells.

Authors:  Mikhail Linetsky; Karina S Bondelid; Sofiya Losovskiy; Vadym Gabyak; Mario J Rullo; Thomas I Stiadle; Vasu Munjapara; Priyali Saxena; Duoming Ma; Yu-Shiuan Cheng; Andrew M Howes; Emeka Udeigwe; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2018-07-09       Impact factor: 3.739

6.  Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.

Authors:  Bert J C Janssen; Lucio Gomes; Roman I Koning; Dmitri I Svergun; Abraham J Koster; David C Fritzinger; Carl-Wilhelm Vogel; Piet Gros
Journal:  EMBO J       Date:  2009-07-02       Impact factor: 11.598

7.  Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.

Authors:  Serena Bettoni; Elena Bresin; Giuseppe Remuzzi; Marina Noris; Roberta Donadelli
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

8.  Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.

Authors:  Meike Heurich; Ruben Martínez-Barricarte; Nigel J Francis; Dawn L Roberts; Santiago Rodríguez de Córdoba; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

9.  Ancylostoma ceylanicum excretory-secretory protein 2 adopts a netrin-like fold and defines a novel family of nematode proteins.

Authors:  Kaury Kucera; Lisa M Harrison; Michael Cappello; Yorgo Modis
Journal:  J Mol Biol       Date:  2011-02-23       Impact factor: 5.469

10.  Improving therapeutic efficacy of a complement receptor by structure-based affinity maturation.

Authors:  Bing Li; Hongkang Xi; Lauri Diehl; Wyne P Lee; Lizette Sturgeon; Jason Chinn; Laura Deforge; Robert F Kelley; Christian Wiesmann; Menno van Lookeren Campagne; Sachdev S Sidhu
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.